SPARSH BIOTECH is firmly establishing itself as a significant player in the pharmaceutical sector, especially recognized for its cutting-edge process of manufacturing Amoxicilline and Augmentin. The firm boasts state-of-the-art plants and a dedicated team ensuring superior antibiotics serving patients internationally. Via